Avanos Medical Inc (AVNS)
Debt-to-equity ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 828,500 | 1,229,700 | 1,222,000 | 1,227,900 | 1,236,300 | 1,222,100 | 1,234,800 | 1,298,700 | 1,291,200 | 1,263,500 | 1,251,600 | 1,256,500 | 1,263,900 | 1,261,900 | 1,296,300 | 1,252,600 | 1,256,500 | 1,289,900 | 1,261,600 | 1,256,500 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $828,500K
= 0.00
The debt-to-equity ratio for Avanos Medical Inc has consistently been 0.00 for the periods from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 typically indicates that the company has no debt or a negligible amount in comparison to its equity. This implies that the company is primarily funded by equity rather than debt, which can be considered a positive indicator of financial stability and strength. A lower debt-to-equity ratio is generally perceived favorably by investors and creditors as it signifies lower financial risk and leverage. This stable ratio over the years suggests that Avanos Medical Inc has maintained a conservative capital structure, which may be advantageous in terms of financial flexibility and risk management.
Peer comparison
Dec 31, 2024